Logos Global Management LP

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 27, 2024
Value $
$868M
Signature - Title
Derek Gould - GC/CCO
Location
1 Letterman Drive, Bldg C, Suite C3 350, San Francisco, CA
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 51 $868M $0 $0 IDYA, ARGX, MRUS, RVMD, GPCR New Holdings 8/27/2024, 05:11 PM
Q2 2024 51 $868M +$448M -$429M +$19M IDYA, ARGX, MRUS, RVMD, GPCR 13F-HR 8/14/2024, 01:38 PM
Q1 2024 50 $947M +$433M -$433M -$549K IDYA, IMCR, IMVT, OCUL, SRPT 13F-HR 5/15/2024, 04:10 PM
Q4 2023 47 $899M +$329M -$319M +$9.74M CYTK, IDYA, APLS, ARGX, OLMA 13F-HR 2/14/2024, 03:35 PM
Q3 2023 52 $701M +$222M -$221M +$1.82M IMVT, IDYA, OLMA, RCKT, CYTK 13F-HR 11/14/2023, 09:25 AM
Q2 2023 50 $724M +$179M -$263M -$84M APLS, CYTK, IMVT, IDYA, SRPT 13F-HR 8/14/2023, 09:40 AM
Q1 2023 43 $699M +$145M -$204M -$58.8M APLS, IDYA, CYTK, IMVT, ISEE 13F-HR 5/15/2023, 10:19 AM
Q4 2022 40 $854M +$203M -$178M +$24.8M IDYA, APLS, CYTK, IMVT, ALLK 13F-HR 2/14/2023, 10:17 AM
Q3 2022 38 $801M +$222M -$147M +$74.3M APLS, CYTK, IDYA, VTYX, DSGN 13F-HR 11/14/2022, 01:12 PM
Q2 2022 32 $545M +$146M -$257M -$111M CYTK, APLS, IDYA, DSGN, SRPT 13F-HR 8/15/2022, 10:59 AM
Q1 2022 47 $771M +$242M -$291M -$49M CYTK, ALXO, APLS, DSGN, NBIX 13F-HR 5/16/2022, 10:50 AM
Q4 2021 66 $970M +$299M -$500M -$201M ALXO, CYTK, DSGN, BCYC, APLS 13F-HR 2/14/2022, 05:05 PM
Q3 2021 56 $1.38B +$489M -$259M +$231M ALXO, OLMA, DCPH, BCYC, DYN 13F-HR 11/15/2021, 01:44 PM
Q2 2021 57 $1.17B +$460M -$160M +$299M ALXO, OLMA, DSGN, VERV, DYN Restatement 8/17/2021, 04:22 PM
Q1 2021 53 $1.02B +$396M -$312M +$83.5M ALXO, OLMA, DSGN, DYN, TIL 13F-HR 5/17/2021, 04:23 PM
Q4 2020 58 $1.15B +$426M -$400M +$25.5M ALXO, OLMA, NKTX, FMTX, TGTX 13F-HR 2/16/2021, 04:36 PM
Q3 2020 46 $781M +$541M -$257M +$283M ALXO, KROS, NKTX, FMTX, GBT Restatement 11/17/2020, 03:14 PM
Q2 2020 46 $500M +$418M -$199M +$219M FMTX, RETA, CLDX, RNA, RPTX 13F-HR 8/14/2020, 12:23 PM
Q1 2020 40 $260M +$154M -$193M -$39.8M ABBV, SRPT, MYOK, MRNA, ASND 13F-HR 5/15/2020, 11:32 AM
Q4 2019 38 $353M $0 $0 MRTX, SRPT, ASND, AMRN, APLS 13F-HR 2/14/2020, 09:27 AM